At the Recode conference in Rancho Palos Verdes, California, Jesse Karmazin, who leads the small biotech startup Ambrosia, told New Scientist that he had positive results from a preliminary trial injecting older patients with younger plasma,the liquid part of blood that doesn’t contain any cells

Quick Read